课题基金 / 基金详情

HIV-1 Viral protein U (Vpu) as an antagonist of Tetherin/BST2: molecular mechanisms and functional implications for viral replication and transmission

HIV-1 Viral protein U (Vpu) as an antagonist of Tetherin/BST2: molecular mechanisms and functional implications for viral replication and transmission
HIV-1 病毒蛋白 U (Vpu) 作为 Tetherin/BST2 拮抗剂：病毒复制和传播的分子机制和功能意义
批准号：
210347
负责人：
Cohen Eric A
金额：
$51.0万
依托单位：
Institut de recherches cliniques de Montral
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2010
资助国家：
加拿大
项目状态：
已结题
起止时间：
2010-09-01 至 2015-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=210347&lang=en
关键词：
Anti-Tetherin Factors Hiv-1 Release Hiv-1 Transmission Hiv-1/Aids Host Cell Ubiquitin Machinery Protein Trafficking Tetherin/Bst2/Cd317 Viral Protein U (Vpu)

项目摘要

项目成果

Cohen Eric A的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
AIDS is a slow degenerative disease of the immune and nervous systems resulting from HIV-1 infection. Despite considerable progress made in our understanding of HIV-1 infection, we still do not completely understand how the virus causes AIDS and how it ma
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Canadian HIV Cure Enterprise 2.0: Targeting the interplay between myeloid cells and CD4+ T-cells for HIV cure
Targeting of host antiviral and immune-modulatory factors by HIV-1 Vpu: Implications for viral pathogenesis and therapy
Examining the role of plasmacytoid dendritic cells in the control of HIV infection using humanized mice
Human immunodeficiency virus (HIV)-host interactions: from mechanisms of viral persistence to infection control